Medications for Erdheim-Chester Disease
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Erdheim-Chester Disease.
Found 1 Approved Drug for Erdheim-Chester Disease
Zelboraf
Generic Name
Vemurafenib
Zelboraf
Generic Name
Vemurafenib
Form: Tablet
Method of administration: Oral
FDA approval date: August 17, 2011
Classification: Kinase Inhibitor
ZELBORAF ® is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances